Carmen Mir, M. Et Al. 2020. PERFORMANCE OF A NEW RISK ASSESSMENT TOOL FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA UNDERGOING CYTOREDUCTIVE NEPHRECTOMY IN THE TARGETED THERAPY ERA: REMARCC SCORE. Annual Meeting of the American-Urological-Association (AUA) , (Washington, Kiribati).

Carmen Mir, M., Marchioni, M., Campi, R., Minervini, A., Roussel, E., Albertsen, M., ... Capitanio, U.(2020). PERFORMANCE OF A NEW RISK ASSESSMENT TOOL FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA UNDERGOING CYTOREDUCTIVE NEPHRECTOMY IN THE TARGETED THERAPY ERA: REMARCC SCORE . Annual Meeting of the American-Urological-Association (AUA), Washington, Kiribati

Carmen Mir, M. Et Al. "PERFORMANCE OF A NEW RISK ASSESSMENT TOOL FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA UNDERGOING CYTOREDUCTIVE NEPHRECTOMY IN THE TARGETED THERAPY ERA: REMARCC SCORE," Annual Meeting of the American-Urological-Association (AUA), Washington, Kiribati, 2020

Carmen Mir, M. C. Et Al. "PERFORMANCE OF A NEW RISK ASSESSMENT TOOL FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA UNDERGOING CYTOREDUCTIVE NEPHRECTOMY IN THE TARGETED THERAPY ERA: REMARCC SCORE." Annual Meeting of the American-Urological-Association (AUA) , Washington, Kiribati, 2020

Carmen Mir, M. Et Al. (2020) . "PERFORMANCE OF A NEW RISK ASSESSMENT TOOL FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA UNDERGOING CYTOREDUCTIVE NEPHRECTOMY IN THE TARGETED THERAPY ERA: REMARCC SCORE." Annual Meeting of the American-Urological-Association (AUA) , Washington, Kiribati.

@conferencepaper{conferencepaper, author={M. Carmen Mir Et Al. }, title={PERFORMANCE OF A NEW RISK ASSESSMENT TOOL FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA UNDERGOING CYTOREDUCTIVE NEPHRECTOMY IN THE TARGETED THERAPY ERA: REMARCC SCORE}, congress name={Annual Meeting of the American-Urological-Association (AUA)}, city={Washington}, country={Kiribati}, year={2020}}